P Colonna

Fifteen‐year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high‐dose irradiation

Vincent Delwail, Jean-Philippe Jaı̈s, P Colonna et al. · British Journal of Haematology · 2002 · 67 citations · Full text

Alkene Hydroamination <i>via</i> Earth‐Abundant Transition Metal (Iron, Cobalt, Copper and Zinc) Catalysis: A Mechanistic Overview

P Colonna, Sophie Bezzenine, Richard Gil et al. · Advanced Synthesis & Catalysis · 2019 · 67 citations · Full text

Materials Science, Chemical Engineering, Engineering +12

Red cell membrane sialoglycoptein β in homozygous and heterozygous 4.1(−) hereditary elliptocytosis

Nicole Alloisio, Laurette Morlé, D. Bachir et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1985 · 59 citations

Biochemistry, Natural Sciences, Genetics +7

A study of membrane protein defects and α hemoglobin chains of red blood cells in human β thalassemia

P Rouyer-Fessard, M.C. Garel, Chantal Domenget et al. · Journal of Biological Chemistry · 1989 · 49 citations · Full text

Immunohematology, Blood Cell, Membrane Protein Defects +19

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.

P Colonna, B Desablens, J L Harousseau et al. · Journal of Clinical Oncology · 1996 · 48 citations